NOTCH3/JAG1 signaling is associated with immunosuppressive tumor microenvironment features in ovarian cancer: links to nutritional risk, CD163+ macrophages, and CD8+ T cell exclusion
Abstract
BackgroundNOTCH3 signaling is frequently dysregulated in ovarian cancer and has been linked to tumor progression and treatment resistance. We investigated the prognostic significance of NOTCH3 expression and its associations with immune-cell infiltration, nutritional risk, tumor-associated biomarkers, and transcriptional programs in public single-cell RNA-sequencing datasets.MethodsWe retrospectively analyzed 186 patients with epithelial ovarian cancer stratified by immunohistochemistry-assessed NOTCH3 expression (n = 93 per group). Clinicopathological variables, nutritional measures (BMI, serum albumin, and NRS-2002), tumor-associated biomarkers (CA-125 and HE4), immune markers (CD8+, CD4+, CD163+, FOXP3+, and PD-L1), treatment response, and survival were evaluated. Public scRNA-seq datasets were used for complementary exploratory analysis of NOTCH3-associated transcriptional patterns.ResultsNOTCH3-high expression was associated with shorter overall survival, lower CD8+ TIL density, higher CD163+ tumor-associated macrophage density, lower chemotherapy response, and higher platinum resistance. High nutritional risk and hypoalbuminaemia were also associated with an immune-excluded phenotype after adjustment for clinicopathological covariates. The combined NOTCH3-high/NRS-2002 ≥ 3 subgroup had the poorest observed clinical outcomes. In the scRNA-seq analysis, epithelial cells showed the highest NOTCH3-related signature scores, and JAG1 showed the strongest co-expression with NOTCH3 among the evaluated ligands. These findings are associative and do not establish functional ligand-receptor signaling or a causal nutrition-mediated mechanism.ConclusionHigh NOTCH3 expression is associated with an immunosuppressive tumor microenvironment, adverse treatment response, and poorer survival in ovarian cancer. Nutritional risk identifies an additional clinically relevant correlate of immune and survival outcomes. The observational clinical design and exploratory public scRNA-seq analysis do not establish causality; functional validation and prospective studies are required before specific nutritional or NOTCH3-targeted interventions can be recommended.
Related
- Myeloid Lectin Profiling Identifies SYK as a Targetable Signaling Node for Remodeling Immunosuppressive Tumor-Associated Macrophages in Breast Cancer
- Zika virus oncolytic signaling reverts immunosuppressive and angiogenic glioblastoma microenvironment in vitro and in vivo
- Machine learning–derived intracellular protein–based prognostic model reflecting a senescence-associated secretory phenotype-driven immunosuppressive microenvironment in lung adenocarcinoma
- Potential involvement of a TLR4-associated CD155/TIGIT pathway in Porphyromonas gingivalis-induced immunosuppressive microenvironment formation in oral squamous cell carcinoma
- Single-cell RNA Sequencing Analysis Reveals That Targeting PLG–PLGRKT Signaling-mediated Pro-fibrotic Scar-associated Macrophages Ameliorates Liver Fibrosis in Biliary Atresia
BibTeX
@article{zhu2026notch3jag1,
title = {{NOTCH3/JAG1 signaling is associated with immunosuppressive tumor microenvironment features in ovarian cancer: links to nutritional risk, CD163+ macrophages, and CD8+ T cell exclusion}},
author = {Hui Zhu and Ying He and Rui Hao and Xiaochun Li and Hui Wang},
journal = {Frontiers in Public Health},
year = {2026},
month = nov,
doi = {10.3389/fpubh.2026.1968042},
url = {https://www.frontiersin.org/articles/10.3389/fpubh.2026.1968042},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - NOTCH3/JAG1 signaling is associated with immunosuppressive tumor microenvironment features in ovarian cancer: links to nutritional risk, CD163+ macrophages, and CD8+ T cell exclusion
AU - Hui Zhu
AU - Ying He
AU - Rui Hao
AU - Xiaochun Li
AU - Hui Wang
PY - 2026
DA - 2026/11/02
JO - Frontiers in Public Health
DO - 10.3389/fpubh.2026.1968042
UR - https://www.frontiersin.org/articles/10.3389/fpubh.2026.1968042
AB - BackgroundNOTCH3 signaling is frequently dysregulated in ovarian cancer and has been linked to tumor progression and treatment resistance. We investigated the prognostic significance of NOTCH3 expression and its associations with immune-cell infiltration, nutritional risk, tumor-associated biomarkers, and transcriptional programs in public single-cell RNA-sequencing datasets.MethodsWe retrospectively analyzed 186 patients with epithelial ovarian cancer stratified by immunohistochemistry-assessed NOTCH3 expression (n = 93 per group). Clinicopathological variables, nutritional measures (BMI, serum albumin, and NRS-2002), tumor-associated biomarkers (CA-125 and HE4), immune markers (CD8+, CD4+, CD163+, FOXP3+, and PD-L1), treatment response, and survival were evaluated. Public scRNA-seq datasets were used for complementary exploratory analysis of NOTCH3-associated transcriptional patterns.ResultsNOTCH3-high expression was associated with shorter overall survival, lower CD8+ TIL density, higher CD163+ tumor-associated macrophage density, lower chemotherapy response, and higher platinum resistance. High nutritional risk and hypoalbuminaemia were also associated with an immune-excluded phenotype after adjustment for clinicopathological covariates. The combined NOTCH3-high/NRS-2002 ≥ 3 subgroup had the poorest observed clinical outcomes. In the scRNA-seq analysis, epithelial cells showed the highest NOTCH3-related signature scores, and JAG1 showed the strongest co-expression with NOTCH3 among the evaluated ligands. These findings are associative and do not establish functional ligand-receptor signaling or a causal nutrition-mediated mechanism.ConclusionHigh NOTCH3 expression is associated with an immunosuppressive tumor microenvironment, adverse treatment response, and poorer survival in ovarian cancer. Nutritional risk identifies an additional clinically relevant correlate of immune and survival outcomes. The observational clinical design and exploratory public scRNA-seq analysis do not establish causality; functional validation and prospective studies are required before specific nutritional or NOTCH3-targeted interventions can be recommended.
SN - 2296-2565
ER -